Cover Image

Drug-induced modulation of cellular activation during latency reversal changes antigen processing and peptide presentation in primary CD4 T cells

Saved in:

Bibliographic Details
Main Authors:	J. Boucau (Author), A. Sanchez-Bernabeu (Author), S. Le Gall (Author)
Format:	Book
Published:	Elsevier, 2017-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Latency-reversing agents and cellular activation affect antigen processing in primary CD4 T cells
by: J. Boucau, et al.
Published: (2015)

The contribution of memory CD4+ T cell subset phenotype to latency reversal efficiency
by: D.A. Kulpa, et al.
Published: (2017)

Co-culture of T-cells with dendritic cells facilitates HIV latency in proliferating CD4+ T-cells: implications for the establishment and reversal of latency
by: N. Kumar, et al.
Published: (2015)

Memory CD4+ T cell subsets show differential responses to HIV latency-reversing agents
by: D.A. Kulpa, et al.
Published: (2015)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017)

Histone deacetylase inhibitors induce transcription of unspliced but not multiply spliced HIV-1 RNA from proviral genomes during latency reversal, affecting antigen presentation and detection by CD8+ T cells
by: T. Mota, et al.
Published: (2019)

Lymphoid tissue and blood CD4 T cells respond differently to latency-reversing agents: are we testing the right cells?
by: A. Gramatica, et al.
Published: (2015)

PP 1.3 - 00022 Signaling pathways that activate P-TEFb to reverse HIV latency in CD4+ T cells
by: U. Mbonye, et al.
Published: (2022)

PP 1.22 - 00120 Suppression of CD4+ T-cell-intrinsic immunity by HIV-1 latency-reversing HDACi
by: J. Kazmierski, et al.
Published: (2022)

The SMAC mimetic AZD5582 reverses HIV latency as a single agent in resting primary CD4+ T cells
by: G. Sampey, et al.
Published: (2019)

Insights into mechanisms of HIV reactivation from latency using RNA-Seq gene expression profiling in CD4+ T cells and their maturation subsets following treatment with latency reversing agents.
by: N. Beliakova-Bethell, et al.
Published: (2017)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

HIV-1 transcriptional latency in resting CD4 T-cell
by: M. Benkirane
Published: (2015)

Unprimed CD8 lymphocytes promote the establishment of HIV latency in CD4 T cells
by: L. Franchitti, et al.
Published: (2019)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019)

Approaches to discover latency-reversing agents
Published: (2015)

OP 2.8 - 00193 Enhancing PKC Modulator HIV Latency Reversing Agents
by: M. Marsden, et al.
Published: (2022)

Evaluation of HIV latency reversal using designed PKC modulators in humanized BLT mice
by: M.D. Marsden, et al.
Published: (2015)

Defining the Effects of PKC Modulator HIV Latency-Reversing Agents on Natural Killer Cells
by: Melanie Dimapasoc, et al.
Published: (2024)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

Sustained HIV release by single persisting CD4+ T cells during latency disruption
by: J.M. Hataye, et al.
Published: (2015)

Single-cell transcriptomics to evaluate HIV latency establishment in primary CD4 T cells
by: L. De Armas, et al.
Published: (2017)

30 Changes in expression of small non-coding RNA during HIV infection and latency in a CD4+ T cell model of HIV latency
by: SaiVikram Vemula, et al.
Published: (2017)

PP 5.4 - 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents
by: L. Pache, et al.
Published: (2022)

Maraviroc reactivates HIV with a potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells
by: S. Moreno, et al.
Published: (2019)

Aptamers for CD Antigens: From Cell Profiling to Activity Modulation
by: Amin Nozari, et al.
Published: (2017)

OP 4.8 - 00149 CD8+ T cells promote hiv latency in CD4+ T cells through the downmodulation of NF-kB
by: S. Mutascio, et al.
Published: (2022)

An unbiased platform to identify regulators of HIV latency in infected primary human CD4 T Cells
by: U. Rathore, et al.
Published: (2019)

Identification of a promising new class of latency reversing agents
by: A. Gramatica, et al.
Published: (2017)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

Induction of CD4(+)CD25(+)FOXP3(+) regulatory T cells during human hookworm infection modulates antigen-mediated lymphocyte proliferation.
by: Natasha Delaqua Ricci, et al.
Published: (2011)

P1 Contribution of lncRNAs in the establishment of HIV latency in central memory CD4 T Cells
by: Wim Trypsteen, et al.
Published: (2017)

PP 1.1 - 00009 TB-associated microenvironment promotes HIV latency in CD4+ T cells
by: G. Duette, et al.
Published: (2022)

Integration site-independent enhancement of latency reversal by HIV-1 Nef
by: X.T. Kuang, et al.
Published: (2017)

Cleavage and polyadenylation specific factor 6 is required for HIV latency reversal
by: Y. Zheng, et al.
Published: (2019)

OP 2.7 - 00057 The latency reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific CD8+ T-cells
by: D.C. Copertino, et al.
Published: (2022)

The latency reversal activity of the SMAC mimetic AZD5582 in ART-suppressed SIV-infected rhesus macaques is potentiated by CD8a cell depletion
by: M. Mavigner, et al.
Published: (2019)

CD8 depletion plus signaling of the non-canonical NF-kB pathway reverses latency in SIV-infected, ART-suppressed rhesus macaques
by: M. Mavigner, et al.
Published: (2019)

Synergistic HIV latency reversal from an in vitro screen of epigenetic and kinase inhibitors
by: D. Irlbeck, et al.
Published: (2017)

Novel use of alprazolam as a potential HIV-1 latency reversing agent
by: W. Elbezanti, et al.
Published: (2017)